Saturday 18 May 7 sessions
Sunday 19 May 45 sessions
Monday 20 May 41 sessions
Tuesday 21 May 38 sessions
Elena Rapizzi
Elena Rapizzi
OC5.2
Mon 20 12:00 Oral Communications 5: Adrenal 2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Juan Jiménez-Vacas
Juan Jiménez-Vacas
OC5.3
Mon 20 12:00 Oral Communications 5: Adrenal 2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Sergio Pedraza-Arévalo
Sergio Pedraza-Arévalo
OC5.4
Mon 20 12:00 Oral Communications 5: Adrenal 2
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Andrea Widmer
Andrea Widmer
OC5.5
Mon 20 12:00 Oral Communications 5: Adrenal 2
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
Michael Culler
Michael Culler
OC6.1
Mon 20 12:00 Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Anna Ferrulli
Anna Ferrulli
OC6.2
Mon 20 12:00 Oral Communications 6: Obesity 1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Arnaud Jannin
Arnaud Jannin
OC6.4
Mon 20 12:00 Oral Communications 6: Obesity 1
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Michal Meron
Michal Meron
OC6.5
Mon 20 12:00 Oral Communications 6: Obesity 1
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Carmen Aresta
Carmen Aresta
OC7.1
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Laura Bessiène
Laura Bessiène
OC7.2
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
Volha Zhukouskaya
Volha Zhukouskaya
OC7.3
Mon 20 12:00 Oral Communications 7: Endocrine Connections
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Anne Barlier
Anne Barlier
OC7.4
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Linda Humbert
Linda Humbert
OC7.5
Mon 20 12:00 Oral Communications 7: Endocrine Connections
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Alberto Arias
Alberto Arias
ERN1.1
Mon 20 13:00 Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Lars Rejnmark
Lars Rejnmark
ERN1.2
Mon 20 13:00 Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Danielle Steenvoorden
Danielle Steenvoorden
ERN1.3
Mon 20 13:00 Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Gabor Tamas
Gabor Tamas
NSA3
Mon 20 14:00 New Scientific Approach 3
Intelligent image based in situ single cell isolation
Anca Bucur
Anca Bucur
NSA4
Mon 20 14:00 New Scientific Approach 4
When will AI take over from the endocrinologist?
David Unuane
David Unuane
S16.1
Mon 20 15:00 Symposium 16: Thyroid in pregnancy
Thyroid autoimmunity and fertility
Fereidoun Azizi
Fereidoun Azizi
S16.2
Mon 20 15:00 Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Deborah Levie
Deborah Levie
S16.3
Mon 20 15:00 Symposium 16: Thyroid in pregnancy
Thyroid disease and offspring development
Jacques Drouin
Jacques Drouin
S17.1
Mon 20 15:00 Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Dr Cynthia Andoniadou
Cynthia Andoniadou
S17.2
Mon 20 15:00 Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
Peter Kamenicky
Peter Kamenicky
S17.3
Mon 20 15:00 Symposium 17: Where Do Pituitary Tumours Come From
From Lab to Clinic - Can we translate into effective therapeutics
Paolo Forni
Paolo Forni
S18.1
Mon 20 15:00 Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
GnRH migration and vomeronasal neurons
Andrea Messina
Andrea Messina
S18.2
Mon 20 15:00 Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Flipping the GnRH switch with microRNAs
Jacques Young
Jacques Young
S18.3
Mon 20 15:00 Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Eystein Husebye
Eystein Husebye
S19.1
Mon 20 15:00 Symposium 19: Adrenal Insufficiency
New insights into autoimmune adrenal insufficiency
Gudmundur Johannsson
Gudmundur Johannsson
S19.2
Mon 20 15:00 Symposium 19: Adrenal Insufficiency
Long-term results of slow acting glucocorticoids - are they really better?
Carlos Celis-Morales
Carlos Celis-Morales
S20.1
Mon 20 15:00 Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Denise Robertson
Denise Robertson
S20.2
Mon 20 15:00 Symposium 20: News on Nutrition: When to eat what
Is limiting the timing of food intake a viable nutritional approach?
Emilio Ros
Emilio Ros
S20.3
Mon 20 15:00 Symposium 20: News on Nutrition: When to eat what
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Renato Santini
Renato Santini
GS1
Mon 20 15:00 Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Susan Webb
Susan Webb
CET1
Mon 20 16:50 Plenary: Clinical Endocrinology Trust Lecture
How can patients perception of outcome be improved after controlling pituitary disease?
Hervé Lefebvre
Hervé Lefebvre
PL5
Mon 20 17:20 Plenary 5
Paracrine regulation of the adrenal cortex
Nuria Guanabens
Nuria Guanabens
MTE11
Tue 21 08:00 Meet The Expert 11: Calcium and Bone
Shifting treatment paradigms in osteoporosis
Cyrille Confavreux
Cyrille Confavreux
MTE12
Tue 21 08:00 Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Laura Graaff
Laura Graaff
MTE14
Tue 21 08:00 Meet The Expert 14: Interdisciplinary Endocrinology
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Marianne Klose
Marianne Klose
MTE15
Tue 21 08:00 Meet The Expert 15: Pituitary and Neuroendocrinology
To what degree does hypopituitarism exist after TBI?
Martin Bidlingmaier
Martin Bidlingmaier
MTE16.2
Tue 21 08:00 Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Julio Abucham
Julio Abucham
MTE16.1
Tue 21 08:00 Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
John-Olov Jansson
John-Olov Jansson
MTBS3
Tue 21 08:00 Meet The Basic Scientist 3
The “Gravitostat” – How does it relate to hormones?
Professor George Kahaly
George Kahaly
PL6
Tue 21 08:50 Plenary 6
Treatment strategies for Graves orbitopathy
Alberto Davalos
Alberto Davalos
D4.2
Tue 21 09:50 Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Edit Buzás
Edit Buzás
D4.1
Tue 21 09:50 Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Antonella Forlino
Antonella Forlino
S21.1
Tue 21 09:50 Symposium 21: Rare Bone Disorders
Animal model of bone fragility
Valérie Cormier-Daire
Valérie Cormier-Daire
S21.2
Tue 21 09:50 Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Victor Navarro
Victor Navarro
S22.1
Tue 21 09:50 Symposium 22: The Pituitary As Metabolic Sensor
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Giovanni Tulipano
Giovanni Tulipano
S22.2
Tue 21 09:50 Symposium 22: The Pituitary As Metabolic Sensor
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Raul Luque
Raul Luque
S22.3
Tue 21 09:50 Symposium 22: The Pituitary As Metabolic Sensor
Bidirectional interrelationship between growth hormone and metabolism
María Insenser
María Insenser
S23.1
Tue 21 09:50 Symposium 23: PCOS: Can we personalise treatment?
Gut brain axis
Mojca Sever
Mojca Sever
S23.3
Tue 21 09:50 Symposium 23: PCOS: Can we personalise treatment?
Treatment options in cardiometabolic PCOS phenotype
Guillaume Assie
Guillaume Assie
S24.1
Tue 21 09:50 Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Tracy Williams
Tracy Williams
S24.2
Tue 21 09:50 Symposium 24: What's new in the Adrenal Cortex?
Primary hyperaldosteronism: does our treatment work?
Iacopo Chiodini
Iacopo Chiodini
S24.3
Tue 21 09:50 Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Guadalupe Sabio
Guadalupe Sabio
S25.1
Tue 21 09:50 Symposium 25: Late breaking
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Rima Smith
Rima Smith
S25.2
Tue 21 09:50 Symposium 25: Late breaking
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Panagiotis Filis
Panagiotis Filis
S25.3
Tue 21 09:50 Symposium 25: Late breaking
Maternal smoking and high BMI disrupt thyroid gland development
Josef Koehrle
Josef Koehrle
PS1.1
Tue 21 09:50 Publishing Session
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Gesthimani Mintziori
Gesthimani Mintziori
PS1.2
Tue 21 09:50 Publishing Session
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Olaf Dekkers
Olaf Dekkers
PS1.3
Tue 21 09:50 Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Elizabeth Baranowski
Elizabeth Baranowski
OC10.1
Tue 21 11:30 Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Géraldine Vitellius
Géraldine Vitellius
OC10.2
Tue 21 11:30 Oral Communications 10: Adrenal 1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Anna Vaczlavik
Anna Vaczlavik
OC10.3
Tue 21 11:30 Oral Communications 10: Adrenal 1
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Isadora Cavalcante
Isadora Cavalcante
OC10.4
Tue 21 11:30 Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Graham Roberts
Graham Roberts
UEMS1.2
Tue 21 11:30 UEMS Session
Update on European Exam in Endocrinology
Maeve Durkan
Maeve Durkan
UEMS1.1
Tue 21 11:30 UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Mirela Ilie
Mirela Ilie
UEMS1.3
Tue 21 11:30 UEMS Session
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
Sopio Tatulashvili
Sopio Tatulashvili
OC11.1
Tue 21 11:30 Oral Communications 11: Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
David Selva
David Selva
OC11.2
Tue 21 11:30 Oral Communications 11: Diabetes 2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
Hye Chung
Hye Chung
OC11.3
Tue 21 11:30 Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Daisy Crispim
Daisy Crispim
OC11.4
Tue 21 11:30 Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Mariasara Persano
Mariasara Persano
OC11.5
Tue 21 11:30 Oral Communications 11: Diabetes 2
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Elizabeth Winter
Elizabeth Winter
OC12.1
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Laurence Dumeige
Laurence Dumeige
OC12.2
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Prudencio Sáez-Martínez
Prudencio Sáez-Martínez
OC12.3
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Emilie Merlen
Emilie Merlen
OC12.4
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Justine Defreyne
Justine Defreyne
OC12.5
Tue 21 11:30 Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Justine Defreyne
Justine Defreyne
OC14.2
Tue 21 11:30 Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Bettina Winzeler
Bettina Winzeler
OC13.1
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Julie Refardt
Julie Refardt
OC13.2
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Pedro Marques
Pedro Marques
OC13.3
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
Birgitte Damholt
Birgitte Damholt
OC13.4
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Mario Neou
Mario Neou
OC13.5
Tue 21 11:30 Oral Communcations 13: Anteria and posteria pituitary
Pan-genomic classification of Pituitary Adenomas
Giulia Rastrelli
Giulia Rastrelli
OC14.1
Tue 21 11:30 Oral Communications 14: Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Isabelle Beau
Isabelle Beau
OC14.3
Tue 21 11:30 Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Dorte Glintborg
Dorte Glintborg
OC14.4
Tue 21 11:30 Oral Communications 14: Sex Hormones
Thyroid diseases in Danish women with polycystic ovary syndrome.
Claus Gravholt
Claus Gravholt
OC14.5
Tue 21 11:30 Oral Communications 14: Sex Hormones
The pattern of cancer occurrence in Turner syndrome
Carsten Carlberg
Carsten Carlberg
NSA5
Tue 21 13:30 New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Pauline Campos
Pauline Campos
NSA6
Tue 21 13:30 New Scientific Approach 6
Brain imaging in conscious mice
Barbara Obermayer-Pietsch
Barbara Obermayer-Pietsch
D5.2
Tue 21 14:30 Debate 5: Should we treat young osteoporotic patients
AGAINST: No, we shouldn't treat young osteoporotic patients
Serge Ferrari
Serge Ferrari
D5.1
Tue 21 14:30 Debate 5: Should we treat young osteoporotic patients
FOR: Yes, we should treat young osteoporotic patients
Bernard Lerer
Bernard Lerer
S26.1
Tue 21 14:30 Symposium 26: Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Maria Barreto-Chaves
Maria Barreto-Chaves
S26.3
Tue 21 14:30 Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Kirsty Walters
Kirsty Walters
S27.1
Tue 21 14:30 Symposium 27: What's new in reproductive endocrinology?
Dissecting Androgens in PCOS
Frank Tuttelmann
Frank Tuttelmann
S27.2
Tue 21 14:30 Symposium 27: What's new in reproductive endocrinology?
Large scale genetic studies in male infertility
Irene Lambrinoudaki
Irene Lambrinoudaki
S27.3
Tue 21 14:30 Symposium 27: What's new in reproductive endocrinology?
Menopause and cardiovascular risk
Elisabeth Winter
Elisabeth Winter
S28.1
Tue 21 14:30 Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and its metabolites
Suvi Virtanen
Suvi Virtanen
S28.2
Tue 21 14:30 Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and Type 1 Diabetes
Jean Souberbielle
Jean Souberbielle
S28.3
Tue 21 14:30 Symposium 28: Vitamin D - non-skeletal effects in RCTs
How and when to measure Vitamin D
Pim Ronde
Pim Ronde
S29.2
Tue 21 14:30 Symposium 29: Endocrine controversies in sport
Performance enhancing drugs in young males
Guan Wang
Guan Wang
S29.3
Tue 21 14:30 Symposium 29: Endocrine controversies in sport
Omics to fight doping
Dale Abel
Dale Abel
S30.1
Tue 21 14:30 Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Jochen Seufert
Jochen Seufert
S30.3
Tue 21 14:30 Symposium 30: Personalised medicine in diabetes and obesity
Curing diabetes with alternatives: bariatric surgery
Esben Søndergaard
Esben Søndergaard
EYIJC1
Tue 21 16:30 ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Miguel López
Miguel López
EYIJC2
Tue 21 16:30 ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Jens Brüning
Jens Brüning
PL7
Tue 21 17:00 Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Professor Mirjam Christ-Crain
Mirjam Christ-Crain
EJE1
Sat 18 18:20 Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
Professor John Wilding
John Wilding
S30.2
Tue 21 14:30 Symposium 30: Personalised medicine in diabetes and obesity
New avenues for novel drugs to treat obesity
Hannah Nieto
Hannah Nieto
OC9.3
Mon 20 12:00 Oral Communications 9: Thyroid 1
Novel driver mutations in thyroid cancer recurrence
Professor Giles Yeo
Giles Yeo
S13.3
Mon 20 10:20 Symposium 13: Central Control of Metabolism: Brain rules all
Genetics of appetite regulation
Dr Rachel Crowley
Rachel Crowley
NPD2.2
Mon 20 10:20 Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Felix Beuschlein
Felix Beuschlein
PEM1.3
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Nils Krone
Nils Krone
S19.3
Mon 20 15:00 Symposium 19: Adrenal Insufficiency
Optimising care delivery in Congenital Adrenal Hyperplasia
Dr Sasha Howard
Sasha Howard
S2.3
Sun 19 10:20 Symposium 2: Trends in Puberty
Genetic basis in puberty
Angelica Hirschberg
Angelica Hirschberg
S29.1
Tue 21 14:30 Symposium 29: Endocrine controversies in sport
Female hyperandrogenism and elite sport
Martine Cools
Martine Cools
S8.2
Sun 19 15:00 Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ken Ong
Ken Ong
PL2
Sun 19 09:20 Plenary 2
Genetic epidemiology of puberty timing and reproductive lifespan
Professor Stefan Wudy
Stefan Wudy
NSA1
Sun 19 14:00 New Scientific Approach 1
Steroidomics
Professor Anne-Simone Parent
Anne-Simone Parent
S2.2
Sun 19 10:20 Symposium 2: Trends in Puberty
Endocrine disruptors in puberty
Kassim Javaid
Kassim Javaid
S21.3
Tue 21 09:50 Symposium 21: Rare Bone Disorders
Osteogenesis imperfecta throughout life
Dr Ruth Casey
Ruth Casey
OC1.1
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Dr Cristina Ronchi
Cristina Ronchi
OC10.5
Tue 21 11:30 Oral Communications 10: Adrenal 1
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
Dr David Ray
David Ray
S3.1
Sun 19 10:20 Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
Daniel Morganstein
Daniel Morganstein
NS1.2
Sun 19 10:20 Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
Martin Schlumberger
Martin Schlumberger
S1.3
Sun 19 10:20 Symposium 1: Thyroid in cancer
New paradigms in the treatment of low risk thyroid cancer
Chris McCabe
Chris McCabe
S1.2
Sun 19 10:20 Symposium 1: Thyroid in cancer
Iodine refractoriness in thyroid cells
Pierre Bouloux
Pierre Bouloux
MTE13
Tue 21 08:00 Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Graham Williams
Graham Williams
S26.2
Tue 21 14:30 Symposium 26: Impact of thyroid disease on...
Bone
Günter Stalla
Günter Stalla
GH1
Sat 18 17:45 Plenary: Geoffrey Harris Award Lecture
Translational research in pituitary disease
Avi Friedman
Avi Friedman
PL1
Sat 18 19:00 Plenary 1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Christophe Block
Christophe Block
MTE1
Sun 19 08:00 Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Roberto Vettor
Roberto Vettor
MTE2
Sun 19 08:00 Meet The Expert 2: Diabetes, Obesity and Metabolism
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Andrzej Januszewicz
Andrzej Januszewicz
MTE3
Sun 19 08:00 Meet The Expert 3: Adrenal and Neuroendocrine Tumours
The management of primary aldosteronism
Professor Nicole Reisch
Nicole Reisch
MTE4
Sun 19 08:00 Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Management of a life-long disease in CAH
Laurence Leenhardt
Laurence Leenhardt
MTE5
Sun 19 08:00 Meet The Expert 5: Thyroid
Risk classification of thyroid nodules by ultrasound and indications for FNA
Lars Gormsen
Lars Gormsen
MTBS1
Sun 19 08:00 Meet The Basic Scientist 1: Interdisciplinary Endocrinology
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Andrea Giustina
Andrea Giustina
PEM1.1
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Andrea Giustina
Andrea Giustina
PEM1.5
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Closing remarks and discussion
Jerome Bertherat
Jerome Bertherat
PEM1.2
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
Anneke Beukel
Anneke Beukel
PEM1.4
Sun 19 08:00 Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Laura Fugazzola
Laura Fugazzola
S1.1
Sun 19 10:20 Symposium 1: Thyroid in cancer
What is the value of molecular markers in nodules
Alejandro Lomniczi
Alejandro Lomniczi
S2.1
Sun 19 10:20 Symposium 2: Trends in Puberty
Exploring the Epigenetic Landscape of Puberty
Andrea Isidori
Andrea Isidori
S3.2
Sun 19 10:20 Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Fixing the Broken Clock in Adrenal Disorders
Takashi Yoshimura
Takashi Yoshimura
S3.3
Sun 19 10:20 Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Light Up Your Sex Life!
Maria Stelmachowska-Banas
Maria Stelmachowska-Banas
S4.2
Sun 19 10:20 Symposium 4: Immunology and endocrinology
Clinical: Immunotherapy and endocrine disease
Olle Kämpe
Olle Kämpe
S4.3
Sun 19 10:20 Symposium 4: Immunology and endocrinology
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Patrizio Caturegli
Patrizio Caturegli
S4.1
Sun 19 10:20 Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Hubert Vidal
Hubert Vidal
S5.1
Sun 19 10:20 Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
Max Nieuwdorp
Max Nieuwdorp
S5.2
Sun 19 10:20 Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Fecal transplantation: Myth or reality
Matthias Laudes
Matthias Laudes
S5.3
Sun 19 10:20 Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Targeted Microbiome Intervention for handling insulin resistance
Jeff Holly
Jeff Holly
SS1.1
Sun 19 10:20 Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Obesity gives you cancer: the bigger picture!
Erin Hanlon
Erin Hanlon
SS1.2
Sun 19 10:20 Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Sleep Deficiency: A Pathway to Obesity
Felipe Casanueva
Felipe Casanueva
SS1.3
Sun 19 10:20 Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Christelle Fouchardiere
Christelle Fouchardiere
NS1.1
Sun 19 10:20 Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Overview of Immunotherapy: Indications and adverse effects
Mr Sherwin Criseno
Sherwin Criseno
NS1.3
Sun 19 10:20 Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Fernando Fernandez-Aranda
Fernando Fernandez-Aranda
C1.1
Sun 19 12:00 Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Djuro Macut
Djuro Macut
ECAS1.1
Sun 19 12:00 ESE Council of Affiliated Societies Session
Mapping Endocrinology in Europe - ECAS report
George Mastorakos
George Mastorakos
ECAS1.2
Sun 19 12:00 ESE Council of Affiliated Societies Session
Centres of special interest - how could we move on?
Bulent Yildiz
Bulent Yildiz
ECAS1.3
Sun 19 12:00 ESE Council of Affiliated Societies Session
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Federica Saponaro
Federica Saponaro
OC1.2
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Sabrina Corbetta
Sabrina Corbetta
OC1.3
Sun 19 12:00 Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Kristina Chen
Kristina Chen
OC1.4
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Heide Siggelkow
Heide Siggelkow
OC1.5
Sun 19 12:00 Oral Communications 1: Calcium and Bone
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Ruth Northway
Ruth Northway
MTNE1
Sun 19 12:00 Nurses Session 2: Meet the Nurse Expert
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Sari Mäkimattila
Sari Mäkimattila
OC2.1
Sun 19 12:00 Oral Communications 2: Diabetes 1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Qiaoran Liu
Qiaoran Liu
OC2.2
Sun 19 12:00 Oral Communications 2: Diabetes 1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Chiranjit Ghosh
Chiranjit Ghosh
OC2.3
Sun 19 12:00 Oral Communications 2: Diabetes 1
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Narjes Nasiri-Ansari
Narjes Nasiri-Ansari
OC2.4
Sun 19 12:00 Oral Communications 2: Diabetes 1
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Shelley Harris
Shelley Harris
OC2.5
Sun 19 12:00 Oral Communications 2: Diabetes 1
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Rosario Pivonello
Rosario Pivonello
OC3.1
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Athanasios Fountas
Athanasios Fountas
OC3.2
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Jiang-Ning Zhou
Jiang-Ning Zhou
OC3.3
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Mai Arlien-Søborg
Mai Arlien-Søborg
OC3.4
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Eva Coopmans
Eva Coopmans
OC3.5
Sun 19 12:00 Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Marta Astigarraga
Marta Astigarraga
OC4.1
Sun 19 12:00 Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Meir Frankel
Meir Frankel
OC4.2
Sun 19 12:00 Oral Communications 4: Thyroid 2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Nadia Bouzehouane
Nadia Bouzehouane
OC4.3
Sun 19 12:00 Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Paul Sibilia
Paul Sibilia
OC4.4
Sun 19 12:00 Oral Communications 4: Thyroid 2
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Romana Netea-Maier
Romana Netea-Maier
OC4.5
Sun 19 12:00 Oral Communications 4: Thyroid 2
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Keren Halpern
Keren Halpern
NSA2
Sun 19 14:00 New Scientific Approach 2
Single cell spatial reconstruction of endocrine organs
Marco Medici
Marco Medici
S6.1
Sun 19 15:00 Symposium 6: A better life with thyroid hormone
Prediction of the thyroid axis set-point
Maria Salerno
Maria Salerno
S6.2
Sun 19 15:00 Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in children
Professor Simon Pearce
Simon Pearce
S6.3
Sun 19 15:00 Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in the elderly
Jean Fini
Jean Fini
S7.1
Sun 19 15:00 Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Thyroid
Angel Nadal
Angel Nadal
S7.2
Sun 19 15:00 Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Diabetes Mellitus
Bruce Blumberg
Bruce Blumberg
S7.3
Sun 19 15:00 Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Emmanuele Jannini
Emmanuele Jannini
S8.1
Sun 19 15:00 Symposium 8: Gender dysphoria
Psychoendocrinology Of Gender Dysphoria
Nicolas Morel-Journel
Nicolas Morel-Journel
S8.3
Sun 19 15:00 Symposium 8: Gender dysphoria
Gender reassignment surgery in dysphoria
Radu Mihai
Radu Mihai
S9.3
Sun 19 15:00 Symposium 9: Controversies in adrenal disease
Is there a role for subtotal adrenalectomy
Graeme Eisenhofer
Graeme Eisenhofer
S9.1
Sun 19 15:00 Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Mercedes Robledo
Mercedes Robledo
S9.2
Sun 19 15:00 Symposium 9: Controversies in adrenal disease
The do's and don'ts of genetic testing in phaeochromocytoma
Professor Martina Rauner
Martina Rauner
S10.1
Sun 19 15:00 Symposium 10: Cancer drug-induced osteoporosis
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Carola Zillikens
Carola Zillikens
S10.2
Sun 19 15:00 Symposium 10: Cancer drug-induced osteoporosis
Aromatase inhibitors and bone
Claudio Marcocci
Claudio Marcocci
S10.3
Sun 19 15:00 Symposium 10: Cancer drug-induced osteoporosis
TSH-suppressive therapy and bone
Dr Sofia Llahana
Sofia Llahana
NPD1.1
Sun 19 15:00 Nurses Session 3: Professional Development
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
Dr Sofia Llahana
Sofia Llahana
NPD1.3
Sun 19 15:00 Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
Anna Hawkins
Anna Hawkins
NPD1.2
Sun 19 15:00 Nurses Session 3: Professional Development
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
Chris Yedinak
Chris Yedinak
NPD1.5
Sun 19 15:00 Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
Houaria Chanson
Houaria Chanson
NDP1.4
Sun 19 15:00 Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Dr Henri Timmers
Henri Timmers
D1.1
Sun 19 15:15 Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Professor Martin Walz
Martin Walz
D1.2
Sun 19 15:15 Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Susan Bonner-Weir
Susan Bonner-Weir
PL3
Sun 19 17:00 Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Tomaz Kocjan
Tomaz Kocjan
MTE6
Mon 20 08:00 Meet The Expert 6: Calcium and Bone
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Davide Carvalho
Davide Carvalho
MTE7
Mon 20 08:00 Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Claus Gravholt
Claus Gravholt
MTE8
Mon 20 08:00 Meet The Expert 8: Reproductive Endocrinology
Co-morbidities in Turner syndrome
Anne Skakkebæk
Anne Skakkebæk
MTE9
Mon 20 08:00 Meet The Expert 9: Reproductive Endocrinology
Co-morbidities in Klinefelter syndrome
Eda Ertorer
Eda Ertorer
MTE10
Mon 20 08:00 Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Eckhard Wolf
Eckhard Wolf
MTBS2
Mon 20 08:00 Meet The Basic Scientist 2
Genetically tailored pig models in translational endocrine and metabolic research
Juleen Zierath
Juleen Zierath
PL4
Mon 20 08:50 Plenary 4
Exercise training in the management of T2D
Jens Bollerslev
Jens Bollerslev
EHM1
Mon 20 09:20 Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
James Hennessey
James Hennessey
D2.2
Mon 20 10:20 Debate 2: T4 is not enough
AGAINST: No, T4 is enough
Birte Nygaard
Birte Nygaard
D2.1
Mon 20 10:20 Debate 2: T4 is not enough
FOR: Yes, T4 is not enough
Moncef Benkhalifa
Moncef Benkhalifa
S11.1
Mon 20 10:20 Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Patrick Fénichel
Patrick Fénichel
S11.2
Mon 20 10:20 Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Katharina Main
Katharina Main
S11.3
Mon 20 10:20 Symposium 11: EDCs and reproduction
Mitigating against endocrine disruption in pregnancy
Stephanie Puget
Stephanie Puget
S12.1
Mon 20 10:20 Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
Tareq Juratli
Tareq Juratli
S12.2
Mon 20 10:20 Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
New potential treatment alternatives in patients with papillary craniopharyngioma
Eva- Erfurth
Eva- Erfurth
S12.3
Mon 20 10:20 Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
J. Betley
J. Betley
S13.1
Mon 20 10:20 Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Marc Claret
Marc Claret
S13.2
Mon 20 10:20 Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Emanuel Christ
Emanuel Christ
S14.1
Mon 20 10:20 Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Halfdan Sorbye
Halfdan Sorbye
S14.2
Mon 20 10:20 Symposium 14: Innovations in NETs
A role for radionuclide therapy for high-grade NETs
Giovanni Vitale
Giovanni Vitale
S14.3
Mon 20 10:20 Symposium 14: Innovations in NETs
Fishing for NETs
Peter Aldiss
Peter Aldiss
S15.1
Mon 20 10:20 Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Andrea Lovdel
Andrea Lovdel
S15.2
Mon 20 10:20 Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Ashley Castellanos
Ashley Castellanos
S15.3
Mon 20 10:20 Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Ashley Castellanos
Ashley Castellanos
OC6.3
Mon 20 12:00 Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Benjamin Bouillet
Benjamin Bouillet